The Food and Drug Administration is proposing to withdraw from the market a widely used antihistamine called Seldane. It says that the very rare occurence of potentially fatal heart disease outweighs the drug's benefits. A new variant of the drug was just approved by the FDA four months ago, and the agency is advising patients to ask their doctors whether to switch antihistamines. NPR's Vicky Que (KWAY) reports.
Copyright 1997 NPR
